Stock data
X4 Pharmaceuticals, Inc. (XFOR)
X4 Pharmaceuticals, Inc. (XFOR) reported revenue of US$35.11M and net income of -US$79.20M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$35.11M | — | -US$86.88M | -US$79.20M | — |
| 2024 | US$2.56M | — | -US$36.40M | -US$37.45M | — |
| 2023 | US$0.00M | — | -US$107.52M | -US$101.17M | — |
| 2022 | US$0.00M | — | -US$87.57M | -US$93.87M | — |
| 2021 | US$0.00M | — | -US$85.11M | -US$88.70M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$8.81M | -US$16.16M | — |
| 2026-03-31 | US$2.71M | -US$20.24M | — |
| 2025-12-31 | US$2.57M | -US$23.93M | — |
| 2025-09-30 | US$1.76M | -US$29.82M | — |
| 2025-06-30 | US$1.97M | -US$25.74M | — |
| 2025-03-31 | US$28.81M | US$0.28M | — |
| 2024-12-31 | US$1.43M | -US$39.82M | — |
| 2024-09-30 | US$0.56M | -US$36.70M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.